Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Gross Profit: 2022-2024

Historic Gross Profit for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $2.4 million.

  • Orchestra BioMed Holdings' Gross Profit fell 11.64% to $812,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 6.81%. This contributed to the annual value of $2.4 million for FY2024, which is 5.44% down from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Gross Profit is $2.4 million, which was down 5.44% from $2.6 million recorded in FY2023.
  • Orchestra BioMed Holdings' Gross Profit's 5-year high stood at $3.3 million during FY2022, with a 5-year trough of $2.4 million in FY2024.
  • Over the past 3 years, Orchestra BioMed Holdings' median Gross Profit value was $2.6 million (recorded in 2023), while the average stood at $2.8 million.
  • Data for Orchestra BioMed Holdings' Gross Profit shows a maximum YoY declined of 22.52% (in 2023) over the last 5 years.
  • Over the past 3 years, Orchestra BioMed Holdings' Gross Profit (Yearly) stood at $3.3 million in 2022, then fell by 22.52% to $2.6 million in 2023, then dropped by 5.44% to $2.4 million in 2024.